Showing results (1-10 of 114) with videos related to
Sort By:
Pageof 12
International Journal of Medical Informatics|October 15, 2017
What can Google and Wikipedia can tell us about a disease? Big Data trends analysis in Systemic Lupus ErythematosusSavino Sciascia, Massimo RadinCurrent Opinion in Obstetrics & Gynecology|September 16, 2017
Current insights in obstetric antiphospholipid syndromeKaren Schreiber, Massimo Radin, Savino SciasciaCurrent Opinion in Obstetrics & Gynecology|July 18, 2020
Hydroxychloroquine and antiphospholipid antibody-related pregnancy morbidity: a systematic review and meta-analysisMargreta Frishman, Massimo Radin, Karen SchreiberJournal of Investigative Medicine High Impact Case Reports|February 27, 2018
Severe Multi-Organ Failure and Hypereosinophilia: When to Call It "Idiopathic"?Massimo Radin, Luca Bertero, Dario Roccatello, et al.BMJ Case Reports|June 1, 2018
Facilitated subcutaneous immunoglobulin treatment in pemphigus vulgarisMassimo Radin, Dario Roccatello, Simone Baldovino, et al.Internal and Emergency Medicine|January 4, 2017
Novel diagnostic and therapeutic frontiers in thrombotic anti-phospholipid syndromeSavino Sciascia, Massimo Radin, Mario Bazzan, et al.Polish Archives of Internal Medicine|October 21, 2024
How to treat patients with thrombotic antiphospholipid syndrome in 2024?Ciprian Jurcut, Simona Caraiola, Massimo Radin, et al.Lupus|May 20, 2025
JAK inhibitors for the management of rheumatic diseases when antiphospholipid syndrome co-exists: case-based safety considerationsSantiago Dans-Caballero, Irene Cecchi, Massimo Radin, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 31, 2016
Infliximab Biosimilars in the Treatment of Inflammatory Bowel Diseases: A Systematic ReviewMassimo Radin, Savino Sciascia, Dario Roccatello, et al.Autoimmunity Reviews|November 20, 2024
Is it time for treat-to-target in antiphospholipid syndrome?Savino Sciascia, Giuseppe Barilaro, Massimo Radin, et al.Pageof 12